Metabolic disturbances in non-alcoholic fatty liver disease
NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liv...
Saved in:
| Published in | Clinical science (1979) Vol. 116; no. 7; pp. 539 - 564 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Portland Press
01.04.2009
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0143-5221 1470-8736 1470-8736 |
| DOI | 10.1042/CS20080253 |
Cover
| Abstract | NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the ‘gold standard’ for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition. |
|---|---|
| AbstractList | NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the 'gold standard' for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition.NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the 'gold standard' for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition. NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the 'gold standard' for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition. NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the ‘gold standard’ for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition. |
| Author | Byrne, Christopher D. Ahmed, Mohamed H. Cagampang, Felino R. Olufadi, Rasaq Bruce, Kimberley D. |
| Author_xml | – sequence: 1 givenname: Christopher D. surname: Byrne fullname: Byrne, Christopher D. organization: Endocrinology & Metabolism Unit, Institute for Developmental Sciences, University of Southampton and Southampton University Hospitals Trust, Southampton General Hospital, Southampton SO16 6YD, U.K – sequence: 2 givenname: Rasaq surname: Olufadi fullname: Olufadi, Rasaq organization: Chemical Pathology Department, Southampton University Hospitals Trust, Southampton General Hospital, Southampton SO16 6YD, U.K – sequence: 3 givenname: Kimberley D. surname: Bruce fullname: Bruce, Kimberley D. organization: Endocrinology & Metabolism Unit, Institute for Developmental Sciences, University of Southampton and Southampton University Hospitals Trust, Southampton General Hospital, Southampton SO16 6YD, U.K – sequence: 4 givenname: Felino R. surname: Cagampang fullname: Cagampang, Felino R. organization: Centre for Developmental Origins of Health and Disease, Department of Maternal, Fetal & Neonatal Physiology, University of Southampton School of Medicine, Princess Anne Hospital, Southampton SO16 5AY, U.K – sequence: 5 givenname: Mohamed H. surname: Ahmed fullname: Ahmed, Mohamed H. organization: Chemical Pathology Department, Southampton University Hospitals Trust, Southampton General Hospital, Southampton SO16 6YD, U.K |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21252735$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19243311$$D View this record in MEDLINE/PubMed |
| BookMark | eNplkEtLAzEQx4NU7EMvfgDpRQ_Cap67GzxJ8QUVD-o5ZPPASLpbk6zQb29qawWdOcxhfjP_-c8YDNquNQAcI3iBIMWXs2cMYQ0xI3tghGgFi7oi5QCMIKKkYBijIRjH-A4hJjkPwBBxTAlBaASuHk2STeedmmoXUx8a2SoTp66dZpVCetW9fXetTGk19e7ThDVpZDSHYN9KH83Rtk7A6-3Ny-y-mD_dPcyu54UiNUoFYZDSfBGxmiKLZMlMVfKGSIi5pJpCmaO2XDeQ11ZXtdYKMc4N1WVNFCMTcLbZuwzdR29iEgsXlfFetqbroyhLzirMcQZPtmDfLIwWy-AWMqzEj90MnG4BGZX0NmSzLu44jDDDFVkrwg2nQhdjMFYol2RyXZuCdF4gKNafF7-fzyPnf0Z26v_hLwmigM4 |
| CODEN | CSCIAE |
| CitedBy_id | crossref_primary_10_1161_ATVBAHA_112_252932 crossref_primary_10_21673_anadoluklin_824294 crossref_primary_10_1111_jvim_15479 crossref_primary_10_1556_oh_2010_29003 crossref_primary_10_5812_hepatmon_44431 crossref_primary_10_3904_kjm_2015_88_3_273 crossref_primary_10_1002_cpt_1701 crossref_primary_10_1074_jbc_RA118_002377 crossref_primary_10_2174_1381612825666190314124049 crossref_primary_10_4103_tcmj_tcmj_232_24 crossref_primary_10_1155_2012_539426 crossref_primary_10_1155_2012_637538 crossref_primary_10_1007_s11901_019_00497_7 crossref_primary_10_1038_nrneph_2017_16 crossref_primary_10_1007_s00011_014_0778_5 crossref_primary_10_1007_s00247_011_2021_7 crossref_primary_10_1016_j_metabol_2014_01_011 crossref_primary_10_1002_mnfr_201700903 crossref_primary_10_1007_s11033_013_2977_5 crossref_primary_10_1016_j_dld_2015_08_004 crossref_primary_10_1016_j_drudis_2010_06_007 crossref_primary_10_1016_j_metabol_2010_03_006 crossref_primary_10_1155_2018_1053710 crossref_primary_10_1016_j_bioorg_2019_103234 crossref_primary_10_1002_0471140856_tx2301s52 crossref_primary_10_1002_dmrr_2888 crossref_primary_10_1042_CS20220380 crossref_primary_10_1039_D1FO00290B crossref_primary_10_1016_j_atherosclerosis_2010_01_049 crossref_primary_10_3390_biomedicines10061315 crossref_primary_10_1016_j_cmpb_2013_04_020 crossref_primary_10_1124_jpet_112_199919 crossref_primary_10_1042_CS20090565 crossref_primary_10_1016_j_ejrad_2016_04_005 crossref_primary_10_1111_j_1478_3231_2011_02730_x crossref_primary_10_1258_acb_2010_010169 crossref_primary_10_3109_00365513_2010_524933 crossref_primary_10_1002_clc_22529 crossref_primary_10_1007_s11428_009_0457_2 crossref_primary_10_1016_j_biopha_2017_11_072 crossref_primary_10_1016_j_ejphar_2013_12_018 crossref_primary_10_1016_j_ejphar_2014_07_032 crossref_primary_10_1186_1471_230X_10_56 crossref_primary_10_3390_nu11030541 crossref_primary_10_3109_00365521_2010_516452 crossref_primary_10_1002_dmrr_2713 crossref_primary_10_1080_01635581_2023_2205054 crossref_primary_10_1016_j_cca_2011_08_025 crossref_primary_10_3390_ijms24032967 crossref_primary_10_1136_gutjnl_2019_319104 crossref_primary_10_4239_wjd_v12_i9_1576 crossref_primary_10_1042_CS20110060 crossref_primary_10_1007_s10311_019_00896_8 crossref_primary_10_1093_eurheartj_ehr453 crossref_primary_10_1186_1471_230X_12_84 crossref_primary_10_1002_hep_31568 crossref_primary_10_1016_j_celrep_2013_05_030 crossref_primary_10_1016_j_scitotenv_2019_07_192 crossref_primary_10_1007_s11418_019_01356_x crossref_primary_10_1186_s13148_021_01038_0 crossref_primary_10_3109_00365521_2014_894119 crossref_primary_10_3109_00365513_2011_604427 crossref_primary_10_3390_nu6115018 crossref_primary_10_1136_pgmj_2008_078014 crossref_primary_10_1210_jc_2013_1519 crossref_primary_10_1002_dmrr_2269 crossref_primary_10_1002_nbm_1672 crossref_primary_10_5009_gnl_2014_8_3_313 crossref_primary_10_1007_s00394_011_0182_7 crossref_primary_10_4061_2011_136816 crossref_primary_10_1017_jns_2017_28 crossref_primary_10_1016_j_foodchem_2018_03_049 crossref_primary_10_1139_cjpp_2016_0561 crossref_primary_10_1002_dmrr_1291 crossref_primary_10_1155_2013_396545 crossref_primary_10_3389_fendo_2023_1212291 crossref_primary_10_1177_030089161309900102 crossref_primary_10_1186_s12876_015_0400_5 crossref_primary_10_1111_j_1365_2036_2010_04266_x crossref_primary_10_1111_j_1365_2362_2010_02338_x crossref_primary_10_1016_j_jff_2017_06_040 crossref_primary_10_1096_fj_202201950R crossref_primary_10_1530_EJE_16_0608 crossref_primary_10_1089_met_2013_0129 crossref_primary_10_1016_j_ajg_2015_06_001 crossref_primary_10_1016_j_aohep_2022_100765 crossref_primary_10_1007_s12020_011_9530_x crossref_primary_10_1016_j_cct_2018_05_010 crossref_primary_10_1186_s12902_019_0366_3 crossref_primary_10_1186_s13098_015_0099_z crossref_primary_10_1152_ajpendo_00739_2009 crossref_primary_10_1016_j_atherosclerosis_2011_03_026 crossref_primary_10_1097_MD_0000000000039499 crossref_primary_10_1016_j_ejcdt_2012_10_027 crossref_primary_10_1038_s41374_020_00493_2 crossref_primary_10_1152_ajpgi_00434_2009 crossref_primary_10_1161_ATVBAHA_119_312736 crossref_primary_10_1016_j_freeradbiomed_2012_05_012 crossref_primary_10_1016_j_prostaglandins_2020_106501 crossref_primary_10_1016_j_atherosclerosis_2013_01_013 crossref_primary_10_1111_j_1463_1326_2009_01176_x crossref_primary_10_3945_jn_111_153197 crossref_primary_10_1002_hep_31000 crossref_primary_10_1016_j_numecd_2013_07_005 crossref_primary_10_1590_2359_3997000000233 crossref_primary_10_1371_journal_pone_0217797 crossref_primary_10_1016_j_pcd_2010_02_004 crossref_primary_10_1007_s11154_009_9119_3 crossref_primary_10_1016_j_gendis_2017_12_008 crossref_primary_10_4103_0975_7406_199339 crossref_primary_10_1038_srep44844 crossref_primary_10_1161_CIRCRESAHA_111_252981 crossref_primary_10_1016_j_jhep_2011_10_027 crossref_primary_10_3390_ijms232012215 crossref_primary_10_1155_2016_7109270 crossref_primary_10_1016_j_clinre_2015_05_014 crossref_primary_10_1016_j_metabol_2020_154183 crossref_primary_10_1089_jmf_2013_0111 crossref_primary_10_1007_s00281_012_0336_6 crossref_primary_10_6116_kjh_2014_29_1_35 crossref_primary_10_1097_TP_0b013e3181c99185 crossref_primary_10_7717_peerj_9757 crossref_primary_10_1186_1743_7075_11_19 crossref_primary_10_1016_j_cnur_2010_03_005 crossref_primary_10_1177_0004563213487892 crossref_primary_10_1507_endocrj_EJ13_0269 crossref_primary_10_1016_j_amjcard_2015_09_021 crossref_primary_10_1186_s12876_019_0958_4 crossref_primary_10_1515_CCLM_2011_022 crossref_primary_10_2337_dc11_1853 crossref_primary_10_1007_s00394_013_0573_z crossref_primary_10_1007_s40520_013_0156_0 crossref_primary_10_1038_s41374_018_0144_2 crossref_primary_10_1155_2016_4597246 crossref_primary_10_1590_S0004_28032011000300006 crossref_primary_10_30841_2307_5112_5_6_2019_194247 crossref_primary_10_1016_j_clinre_2024_102389 crossref_primary_10_1016_j_plefa_2010_02_016 crossref_primary_10_1186_s12986_017_0213_3 crossref_primary_10_1016_j_jnutbio_2012_02_007 crossref_primary_10_1016_j_plefa_2010_02_012 crossref_primary_10_1016_j_freeradbiomed_2012_09_024 crossref_primary_10_1017_S0029665113001249 crossref_primary_10_1111_j_1464_5491_2012_03732_x crossref_primary_10_1016_j_biopha_2016_02_017 crossref_primary_10_1155_2018_1751583 crossref_primary_10_1016_j_jhep_2010_05_037 crossref_primary_10_5009_gnl_2013_7_4_469 crossref_primary_10_1016_j_appet_2012_09_006 crossref_primary_10_1016_j_arcmed_2010_12_001 crossref_primary_10_2337_dc12_0515 crossref_primary_10_1186_1755_8794_4_71 crossref_primary_10_1155_2013_839275 crossref_primary_10_1016_j_metabol_2010_05_008 crossref_primary_10_1371_journal_pone_0127352 crossref_primary_10_3390_nu12071925 crossref_primary_10_1097_MEG_0000000000001141 crossref_primary_10_1177_1535370217708188 |
| Cites_doi | 10.1056/NEJMra025261 10.1093/ajcn/74.6.737 10.1074/jbc.M111041200 10.1126/science.1061620 10.1002/hep.21223 10.1016/j.dld.2007.10.003 10.1007/s00125-005-0063-9 10.1053/j.gastro.2007.10.010 10.1210/jc.2004-1983 10.1016/S0022-3476(00)05040-X 10.1172/JCI200523962 10.1152/ajpendo.00033.2003 10.1172/JCI25256 10.1007/s00125-007-0705-1 10.1073/pnas.132384699 10.1074/jbc.M111421200 10.1073/pnas.0506925102 10.1210/edrv.23.2.0461 10.1093/ajcn/81.1.35 10.1093/jn/132.11.3333 10.1053/jhep.2002.30692 10.1053/jhep.2003.50290 10.1093/eurheartj/ehn076 10.1016/S1074-7613(00)80042-4 10.1002/0470025131.ch11 10.1017/S0007114507894438 10.1309/JXWUM661T8VT1ETX 10.2337/diabetes.50.8.1844 10.1172/JCI6223 10.1152/ajpendo.00251.2004 10.1053/gast.2001.23256 10.7326/0003-4819-132-2-200001180-00004 10.2337/diabetes.54.7.1907 10.1111/j.1440-1746.2006.04665.x 10.1126/science.1128294 10.1136/gut.2003.019984 10.1126/science.1103160 10.1002/hep.20818 10.1016/j.cmet.2005.04.002 10.1074/jbc.273.52.35299 10.1053/jhep.2003.50229 10.1002/hep.21988 10.1002/hep.21641 10.1053/jhep.2002.33995 10.1111/j.1572-0241.2004.40009.x 10.1074/jbc.M110132200 10.1172/JCI0216784 10.1074/jbc.274.42.29683 10.1042/bj20020430 10.7326/0003-4819-141-12-200412210-00011 10.1055/s-2004-826016 10.1074/jbc.M501949200 10.1038/nature01137 10.1101/gad.14.8.963 10.1016/j.annepidem.2007.05.013 10.1172/JCI23621 10.1210/en.2005-0570 10.1016/j.arcmed.2005.01.005 10.1210/jc.2006-0587 10.1016/j.ccr.2006.12.016 10.1002/hep.20466 10.1001/archinte.164.19.2169 10.1038/35051094 10.1006/jsre.1998.5524 10.1172/JCI13505 10.1053/j.gastro.2005.11.017 10.1074/jbc.275.17.12889 10.1053/j.gastro.2004.08.052 10.1542/peds.2006-1212 10.1080/13813450600711359 10.1002/hep.20283 10.1056/NEJMra011775 10.1152/ajpendo.00117.2003 10.1016/j.cmet.2006.06.008 10.1080/00365520500264953 10.1038/nm788 10.1055/s-2001-12929 10.2337/diabetes.54.12.3541 10.1073/pnas.0603115103 10.1007/s00125-005-0070-x 10.1016/j.drudis.2007.07.009 10.2337/diabetes.54.7.1958 10.1152/ajpregu.00351.2004 10.2337/diacare.26.12.3351-a 10.1007/s00535-003-1178-8 10.1152/ajpendo.00064.2004 10.1038/nature03047 10.1073/pnas.0705667104 10.1073/pnas.90.12.5723 10.1016/j.mito.2005.10.004 10.1172/JCI200319451 10.1210/jcem.84.5.5661 10.2337/diabetes.51.4.1005 10.1073/pnas.97.4.1444 10.1038/nm1166 10.1053/jhep.2003.50048 10.1128/MCB.01122-06 10.1172/JCI34275 10.1016/j.metabol.2007.11.022 10.1053/jhep.2001.29628 10.1016/S0304-4165(98)00002-6 10.1681/ASN.2007101155 10.1111/j.1464-5491.2005.01582.x 10.1002/hep.21171 10.1016/j.cmet.2007.10.014 10.1101/gad.891301 10.1016/S0016-5085(99)70506-8 10.1073/pnas.0308617100 10.2119/2007-00119.Tilg 10.1016/j.cld.2004.04.004 10.1210/endo.141.11.7771 10.1172/JCI34827 10.2337/dc06-0135 10.1016/S0021-9258(18)61616-3 10.1002/hep.20734 10.1016/j.amjmed.2007.08.041 10.1126/science.1056843 10.1017/S0007114507815819 10.1016/S0962-8924(01)81297-6 10.1128/MCB.26.1.63-76.2006 10.1016/S0021-9258(18)80103-X 10.1074/jbc.M313478200 10.1053/jhep.2003.50320 10.1093/jn/135.6.1382 10.1146/annurev.nutr.17.1.77 10.1161/01.ATV.13.2.190 10.3748/wjg.v13.i34.4539 10.1074/jbc.M301982200 10.1073/pnas.95.11.5987 10.1203/pdr.0b013e318045bedb 10.1093/oxfordjournals.aje.a117699 10.1111/j.1365-2036.2006.02885.x 10.1073/pnas.0405238101 10.1093/ajcn/86.2.285 10.1053/jhep.2003.50132 10.1152/ajpendo.0327.2001 10.1111/j.1440-1746.2007.05042.x 10.1016/j.taap.2004.10.001 10.1152/ajplung.00077.2002 10.1016/j.jhep.2005.02.042 10.1074/jbc.M200544200 10.1172/JCI27300 10.1002/hep.21496 10.1074/jbc.274.50.35840 10.1002/hep.20280 10.1017/S0007114507682920 10.1152/ajplegacy.1975.228.2.663 10.1128/MCB.24.3.1007-1021.2004 10.1074/jbc.M204542200 10.1172/JCI118645 10.1093/jn/133.11.3386 10.1259/0007-1285-65-777-774 10.2337/diabetes.52.10.2453 10.1053/gast.2001.25540 10.1016/j.bbrc.2007.08.004 10.1210/mend.15.8.0684 10.1074/jbc.M210062200 10.1016/S0168-8278(03)00480-X 10.1111/j.1440-1746.2006.04640.x 10.1007/s00125-006-0439-5 10.1016/j.mcna.2007.06.001 10.1038/nature00820 10.1007/s00125-007-0629-9 10.1172/JCI20513 10.1007/s00125-003-1223-4 10.1152/ajpendo.00442.2002 10.1016/S0140-6736(02)11310-9 10.1002/hep.510300604 10.1016/j.biochi.2004.11.008 10.1136/gut.2004.057968 10.1042/bj3540189 10.1056/NEJM199907223410406 10.1038/ncpgasthep0186 10.1001/jama.282.17.1659 10.1097/01.alc.0000190659.85025.b3 10.1111/j.1464-5491.2005.01494.x 10.1053/j.gastro.2005.04.014 10.1210/en.2002-0036 10.1073/pnas.0404297101 10.1016/j.plefa.2007.10.028 10.1007/s10620-006-9262-6 10.2337/diabetes.52.12.2882 10.1007/s00125-007-0897-4 10.1080/07315724.2004.10719345 10.1016/S0006-291X(88)81207-5 10.1016/S1097-2765(05)00010-9 10.1172/JCI200319246 10.1111/j.1440-1746.2005.04058.x 10.1128/MCB.21.15.5050-5062.2001 10.1111/j.1582-4934.2004.tb00469.x 10.1017/S0007114507352392 10.1161/01.STR.31.8.1851 10.1042/bst0311152 10.1016/S0021-9150(01)00588-3 10.2337/dc06-2247 10.1172/JCI21625 10.1016/S0168-8278(99)80033-6 10.1016/S1471-4892(03)00068-7 10.1073/pnas.1133426100 10.1002/hep.1840380426 10.1016/S1542-3565(04)00440-9 10.1053/jhep.2003.50095 10.1074/jbc.M202638200 10.3748/wjg.v11.i12.1848 10.1111/j.1440-1746.2007.05157.x 10.1053/jhep.2002.33324 10.1016/j.metabol.2007.10.015 10.1016/j.jhep.2005.03.004 10.1136/gut.2003.037010 10.1007/s00535-007-2060-x 10.1093/jn/132.1.68 10.1016/j.atherosclerosis.2006.04.006 10.1016/S1472-6483(10)61277-1 10.1038/oby.2003.74 10.1194/jlr.M200283-JLR200 10.1074/jbc.272.47.29911 10.1194/jlr.M100354-JLR200 10.1080/08035250500449890 10.1111/j.1572-0241.2004.30159.x 10.1017/S000711450769196X |
| ContentType | Journal Article |
| Copyright | 2009 INIST-CNRS |
| Copyright_xml | – notice: 2009 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1042/CS20080253 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1470-8736 |
| EndPage | 564 |
| ExternalDocumentID | 19243311 21252735 10_1042_CS20080253 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/D001633/1 |
| GroupedDBID | --- 0R~ 0VX 29B 2WC 4.4 5GY 5RE 5VS 6J9 AAYXX ABCQX ABJNI ACGFO ACGFS ADBBV AEGXH AENEX AFFNX AIAGR AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION CS3 DU5 E3Z EBS EJD F5P GX1 H13 HZ~ L7B MV1 O9- P2P P6G RHI RPO TR2 WH7 .55 .GJ 3O- 53G AABGO AAHRG AFFVI AI. EBD EMOBN IQODW MVM NTEUP OHT SV3 VH1 X7M ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c381t-350448733fd41f1a65e769b3a029a4d40aaaa8f9db098fd78ddc1599e4d683c53 |
| ISSN | 0143-5221 1470-8736 |
| IngestDate | Fri Jul 11 16:49:02 EDT 2025 Thu Jan 02 22:03:58 EST 2025 Wed Apr 02 07:25:54 EDT 2025 Thu Apr 24 23:08:41 EDT 2025 Tue Jul 01 03:56:48 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | Endocrinopathy non-alcoholic fatty liver disease (NAFLD) Obesity Diabetes mellitus non-alcoholic steatohepatitis (NASH) Nutrition disorder Hepatic disease Inflammation mitochondrion Medicine Mitochondria Metabolic disorder Non alcoholic steatohepatitis Digestive diseases diabetes Nutritional status |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c381t-350448733fd41f1a65e769b3a029a4d40aaaa8f9db098fd78ddc1599e4d683c53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 19243311 |
| PQID | 66957292 |
| PQPubID | 23479 |
| PageCount | 26 |
| ParticipantIDs | proquest_miscellaneous_66957292 pubmed_primary_19243311 pascalfrancis_primary_21252735 crossref_citationtrail_10_1042_CS20080253 crossref_primary_10_1042_CS20080253 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-04-01 |
| PublicationDateYYYYMMDD | 2009-04-01 |
| PublicationDate_xml | – month: 04 year: 2009 text: 2009-04-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Clinical science (1979) |
| PublicationTitleAlternate | Clin Sci (Lond) |
| PublicationYear | 2009 |
| Publisher | Portland Press |
| Publisher_xml | – name: Portland Press |
| References | Clement (2021113010082138300_B112) 2001; 409 Zhou (2021113010082138300_B109) 2001; 108 Monami (2021113010082138300_B35) 2008; 57 Hui (2021113010082138300_B176) 2004; 40 Faeh (2021113010082138300_B80) 2005; 54 Capanni (2021113010082138300_B74) 2006; 23 Sanyal (2021113010082138300_B193) 2001; 120 Vinciguerra (2021113010082138300_B111) 2006; 112 Pfeffer (2021113010082138300_B174) 1993; 73 Spadaro (2021113010082138300_B75) 2008; 40 Furukawa (2021113010082138300_B181) 2004; 114 Dam-Larsen (2021113010082138300_B16) 2004; 53 Wolfrum (2021113010082138300_B110) 2004; 432 Korsheninnikova (2021113010082138300_B131) 2006; 49 Amarapurkar (2021113010082138300_B8) 2007; 22 Tzatsos (2021113010082138300_B128) 2006; 26 Bullo (2021113010082138300_B145) 2003; 11 Bennett (2021113010082138300_B138) 2003; 3 Yuan (2021113010082138300_B165) 2001; 293 Billiar (2021113010082138300_B69) 1988; 104 Foufelle (2021113010082138300_B100) 2002; 366 Angulo (2021113010082138300_B21) 2002; 346 Adams (2021113010082138300_B18) 2005; 129 Lo (2021113010082138300_B70) 1999; 82 Waite (2021113010082138300_B87) 2002; 132 Cook (2021113010082138300_B197) 1987; 262 Lewis (2021113010082138300_B48) 2002; 23 Chalasani (2021113010082138300_B192) 2003; 37 Marchesini (2021113010082138300_B149) 2001; 50 Novak (2021113010082138300_B71) 2003; 284 Horton (2021113010082138300_B105) 1998; 95 Matsuda (2021113010082138300_B108) 2001; 15 Nakatani (2021113010082138300_B155) 2002; 277 Dixon (2021113010082138300_B5) 2001; 121 Zhao (2021113010082138300_B72) 2004; 23 Ohtsuka (2021113010082138300_B226) 2005; 29 Hui (2021113010082138300_B22) 2003; 38 Chang (2021113010082138300_B43) 2008; 57 Joseph (2021113010082138300_B142) 2002; 277 Kelley (2021113010082138300_B56) 2003; 285 Miyazaki (2021113010082138300_B98) 2007; 6 Duvnjak (2021113010082138300_B183) 2007; 13 Soukas (2021113010082138300_B107) 2000; 14 Cortez-Pinto (2021113010082138300_B157) 1999; 282 Xu (2021113010082138300_B77) 2002; 132 Ginsberg (2021113010082138300_B50) 2005; 36 Browning (2021113010082138300_B2) 2004; 40 Voshol (2021113010082138300_B52) 2003; 144 Miyazaki (2021113010082138300_B57) 2002; 283 Ishii (2021113010082138300_B137) 2004; 101 Stoeckman (2021113010082138300_B133) 2002; 277 Shepherd (2021113010082138300_B139) 1999; 341 Targher (2021113010082138300_B39) 2006; 29 Kim (2021113010082138300_B91) 1997; 17 Diraison (2021113010082138300_B88) 1998; 274 Li (2021113010082138300_B110a) 2003; 100 Ribeiro (2021113010082138300_B186) 2004; 99 Watkins (2021113010082138300_B83) 2003; 133 Chalasani (2021113010082138300_B224) 2004; 99 Burdge (2021113010082138300_B200) 2007; 97 Nishimaki-Mogami (2021113010082138300_B84) 2002; 43 Xu (2021113010082138300_B147) 2003; 112 Angulo (2021113010082138300_B218) 1999; 30 McDevitt (2021113010082138300_B79) 2001; 74 Haidari (2021113010082138300_B81) 2002; 277 Ahmed (2021113010082138300_B227) 2007; 127 Cnop (2021113010082138300_B55) 2002; 51 Sreekumar (2021113010082138300_B161) 2003; 38 Mao (2021113010082138300_B92) 2006; 103 Ahmed (2021113010082138300_B1) 2005 Hruszkewycz (2021113010082138300_B153) 1988; 153 Hudgins (2021113010082138300_B61) 1996; 97 Noga (2021113010082138300_B86) 2002; 277 Ioannou (2021113010082138300_B34) 2006; 43 Holt (2021113010082138300_B213) 2007; 50 bu-Elheiga (2021113010082138300_B89) 2001; 291 Cai (2021113010082138300_B150) 2005; 11 Lam (2021113010082138300_B65) 2003; 284 Haukeland (2021113010082138300_B222) 2005; 40 Chen (2021113010082138300_B152) 1998; 1380 Angulo (2021113010082138300_B25) 2007; 45 Fernandez-Checa (2021113010082138300_B199) 2005; 204 Vasudevan (2021113010082138300_B124) 2004; 24 Targher (2021113010082138300_B36) 2007; 30 Lo (2021113010082138300_B118) 2004; 36 Pessayre (2021113010082138300_B159) 2007; 22 Rosenberg (2021113010082138300_B24) 2004; 127 Park (2021113010082138300_B51) 2005; 289 Ozcan (2021113010082138300_B168) 2006; 313 Burdge (2021113010082138300_B202) 2007; 97 Yoneda (2021113010082138300_B220) 2007; 42 Kim (2021113010082138300_B59) 2003; 52 Holt (2021113010082138300_B28) 2006; 49 McCullough (2021113010082138300_B29) 2004; 8 Dentin (2021113010082138300_B78) 2005; 87 Volzke (2021113010082138300_B40) 2005; 11 Kim (2021113010082138300_B7) 2004; 164 Gary-Bobo (2021113010082138300_B178) 2007; 46 Le Marchand-Brustel (2021113010082138300_B129) 2003; 31 Lizardi-Cervera (2021113010082138300_B219) 2007; 52 Adams (2021113010082138300_B45) 2007; 17 Van Gaal (2021113010082138300_B180) 2008; 29 Lillycrop (2021113010082138300_B208) 2007; 97 Wannamethee (2021113010082138300_B32) 1995; 142 Lillycrop (2021113010082138300_B206) 2005; 135 Postic (2021113010082138300_B47) 2008; 118 Luyckx (2021113010082138300_B62) 2000; 26 Paz (2021113010082138300_B164) 1997; 272 Ono (2021113010082138300_B117) 2001; 15 Yu (2021113010082138300_B123) 2003; 278 Hirosumi (2021113010082138300_B140) 2002; 420 bu-Elheiga (2021113010082138300_B90) 2000; 97 Liang (2021113010082138300_B102) 2002; 277 Jiang (2021113010082138300_B97) 2005; 115 Tang (2021113010082138300_B119) 2005; 280 Tripathy (2021113010082138300_B187) 2003; 52 Chitturi (2021113010082138300_B148) 2002; 35 Samuel (2021113010082138300_B151) 2004; 279 Tolman (2021113010082138300_B30) 2004; 141 Holt (2021113010082138300_B212) 2007; 50 Ozcan (2021113010082138300_B170) 2004; 306 Pasparakis (2021113010082138300_B173) 2002; 417 Chen (2021113010082138300_B141) 2004; 101 Akbar (2021113010082138300_B13) 2003; 26 Feldstein (2021113010082138300_B167) 2004; 40 Wieckowska (2021113010082138300_B225) 2006; 44 Godfrey (2021113010082138300_B205) 2007; 61 Schwimmer (2021113010082138300_B14) 2006; 118 Guzder (2021113010082138300_B26) 2005; 22 McConnell (2021113010082138300_B211) 2004; 9 Yahagi (2021113010082138300_B104) 1999; 274 Burdge (2021113010082138300_B201) 2008; 99 Fassio (2021113010082138300_B19) 2004; 40 Targher (2021113010082138300_B42) 2008; 19 Pessayre (2021113010082138300_B189) 2001; 21 Jousilahti (2021113010082138300_B31) 2000; 31 Marceau (2021113010082138300_B63) 1999; 84 Begriche (2021113010082138300_B209) 2006; 6 Li (2021113010082138300_B194) 2003; 37 Decaux (2021113010082138300_B134) 1989; 264 Gluckman (2021113010082138300_B204) 2007; 104 Wang (2021113010082138300_B67) 2006; 147 Shimomura (2021113010082138300_B106) 2000; 6 Nakashima (2021113010082138300_B116) 2000; 275 Crespo (2021113010082138300_B191) 2001; 34 Kunde (2021113010082138300_B215) 2005; 42 Ratziu (2021113010082138300_B23) 2002; 35 Bellentani (2021113010082138300_B4) 2000; 132 Kersten (2021113010082138300_B154) 1999; 103 Winder (2021113010082138300_B198) 1999; 277 Albano (2021113010082138300_B184) 2005; 54 Lavine (2021113010082138300_B216) 2000; 136 Savage (2021113010082138300_B94) 2006; 116 Ron (2021113010082138300_B169) 2002; 110 Ahmed (2021113010082138300_B101) 2007; 12 DeLong (2021113010082138300_B82) 1999; 274 Perez-Carreras (2021113010082138300_B158) 2003; 38 Luyckx (2021113010082138300_B223) 1998; 24 Noga (2021113010082138300_B85) 2003; 278 Yamaguchi (2021113010082138300_B99) 2008; 47 Jimba (2021113010082138300_B6) 2005; 22 Pessayre (2021113010082138300_B160) 2005; 42 Charlton (2021113010082138300_B46) 2004; 2 Horie (2021113010082138300_B120) 2004; 113 Lillycrop (2021113010082138300_B207) 2008; 100 Fracanzani (2021113010082138300_B38) 2008; 121 Donnelly (2021113010082138300_B49) 2005; 115 Kaser (2021113010082138300_B177) 2005; 54 Mordier (2021113010082138300_B132) 2007; 362 Kreutner (2021113010082138300_B144) 1975; 228 Dentin (2021113010082138300_B136) 2005; 115 Shimomura (2021113010082138300_B103) 1998; 273 Ntambi (2021113010082138300_B96) 2002; 99 Osei-Hyiaman (2021113010082138300_B179) 2008; 118 Marcus (2021113010082138300_B122) 1993; 90 Matteoni (2021113010082138300_B20) 1999; 116 Schindhelm (2021113010082138300_B33) 2007; 191 Fan (2021113010082138300_B10) 2005; 43 Radetti (2021113010082138300_B15) 2006; 95 Nguyen-Duy (2021113010082138300_B58) 2003; 284 Watanabe (2021113010082138300_B115) 2007; 22 Guzder (2021113010082138300_B27) 2006; 49 Harada (2021113010082138300_B93) 2007; 27 Szczepaniak (2021113010082138300_B3) 2005; 288 Tilg (2021113010082138300_B162) 2008; 14 Gual (2021113010082138300_B127) 2003; 46 Ding (2021113010082138300_B188) 2004; 8 Chinnery (2021113010082138300_B210) 2002; 360 Fan (2021113010082138300_B11) 2005; 20 Abdelmalek (2021113010082138300_B44) 2007; 91 Uyeda (2021113010082138300_B135) 2006; 4 Zamara (2021113010082138300_B185) 2004; 40 Nagai (2021113010082138300_B190) 2002; 36 Zhang (2021113010082138300_B214) 2005; 288 Timlin (2021113010082138300_B64) 2005; 81 Burdge (2021113010082138300_B203) 2008; 78 Fukui (2021113010082138300_B113) 2005; 54 Stiles (2021113010082138300_B121) 2004; 101 Bedogni (2021113010082138300_B17) 2005; 42 Schaffler (2021113010082138300_B146) 2005; 2 Nobukuni (2021113010082138300_B130) 2005; 102 Caldwell (2021113010082138300_B156) 1999; 31 Memon (2021113010082138300_B195) 2000; 141 Kojima (2021113010082138300_B9) 2003; 38 Renier (2021113010082138300_B73) 1993; 13 el-Hassan (2021113010082138300_B12) 1992; 65 Zivkovic (2021113010082138300_B66) 2007; 86 Larter (2021113010082138300_B76) 2008; 23 Takano (2021113010082138300_B125) 2001; 21 Yamauchi (2021113010082138300_B175) 2002; 8 Weisberg (2021113010082138300_B182) 2003; 112 Targher (2021113010082138300_B37) 2005; 54 Garg (2021113010082138300_B53) 2004; 350 Zick (2021113010082138300_B126) 2001; 11 Chakravarthy (2021113010082138300_B95) 2005; 1 Mofrad (2021113010082138300_B217) 2003; 37 Westerbacka (2021113010082138300_B60) 2005; 90 Louet (2021113010082138300_B196) 2001; 354 Vinciguerra (2021113010082138300_B114) 2008; 134 Targher (2021113010082138300_B41) 2008; 51 Musso (2021113010082138300_B68) 2003; 37 Luedde (2021113010082138300_B171) 2007; 11 Pirro (2021113010082138300_B221) 2002; 160 Zhang (2021113010082138300_B143) 2003; 44 Dandona (2021113010082138300_B163) 1998; 83 Day (2021113010082138300_B166) 2006; 130 Utzschneider (2021113010082138300_B54) 2006; 91 Tanaka (2021113010082138300_B172) 1999; 10 |
| References_xml | – volume: 350 start-page: 1220 year: 2004 ident: 2021113010082138300_B53 article-title: Acquired and inherited lipodystrophies publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra025261 – volume: 74 start-page: 737 year: 2001 ident: 2021113010082138300_B79 article-title: De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/74.6.737 – volume: 277 start-page: 11019 year: 2002 ident: 2021113010082138300_B142 article-title: Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111041200 – volume: 293 start-page: 1673 year: 2001 ident: 2021113010082138300_B165 article-title: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ publication-title: Science doi: 10.1126/science.1061620 – volume: 44 start-page: 27 year: 2006 ident: 2021113010082138300_B225 article-title: In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.21223 – volume: 40 start-page: 194 year: 2008 ident: 2021113010082138300_B75 article-title: Effects of n−3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease publication-title: Dig. Liver Dis. doi: 10.1016/j.dld.2007.10.003 – volume: 49 start-page: 49 year: 2006 ident: 2021113010082138300_B27 article-title: Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-005-0063-9 – volume: 134 start-page: 268 year: 2008 ident: 2021113010082138300_B114 article-title: PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-κB p65/mTOR- dependent mechanism publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.10.010 – volume: 90 start-page: 2804 year: 2005 ident: 2021113010082138300_B60 article-title: Dietary fat content modifies liver fat in overweight nondiabetic subjects publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2004-1983 – volume: 136 start-page: 734 year: 2000 ident: 2021113010082138300_B216 article-title: Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study publication-title: J. Pediatr. doi: 10.1016/S0022-3476(00)05040-X – volume: 115 start-page: 1030 year: 2005 ident: 2021113010082138300_B97 article-title: Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 publication-title: J. Clin. Invest. doi: 10.1172/JCI200523962 – volume: 284 start-page: E863 year: 2003 ident: 2021113010082138300_B65 article-title: Mechanisms of the free fatty acid-induced increase in hepatic glucose production publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00033.2003 – volume: 115 start-page: 2843 year: 2005 ident: 2021113010082138300_B136 article-title: Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation publication-title: J. Clin. Invest. doi: 10.1172/JCI25256 – volume: 50 start-page: 1698 year: 2007 ident: 2021113010082138300_B213 article-title: Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity publication-title: Diabetologia doi: 10.1007/s00125-007-0705-1 – volume: 99 start-page: 11482 year: 2002 ident: 2021113010082138300_B96 article-title: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.132384699 – volume: 277 start-page: 9520 year: 2002 ident: 2021113010082138300_B102 article-title: Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111421200 – volume: 102 start-page: 14238 year: 2005 ident: 2021113010082138300_B130 article-title: Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0506925102 – volume: 23 start-page: 201 year: 2002 ident: 2021113010082138300_B48 article-title: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes publication-title: Endocr. Rev. doi: 10.1210/edrv.23.2.0461 – volume: 81 start-page: 35 year: 2005 ident: 2021113010082138300_B64 article-title: Temporal pattern of de novo lipogenesis in the postprandial state in healthy men publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/81.1.35 – volume: 132 start-page: 3333 year: 2002 ident: 2021113010082138300_B77 article-title: Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms publication-title: J. Nutr. doi: 10.1093/jn/132.11.3333 – volume: 35 start-page: 373 year: 2002 ident: 2021113010082138300_B148 article-title: NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome publication-title: Hepatology doi: 10.1053/jhep.2002.30692 – volume: 38 start-page: 244 year: 2003 ident: 2021113010082138300_B161 article-title: Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1053/jhep.2003.50290 – volume: 29 start-page: 1761 year: 2008 ident: 2021113010082138300_B180 article-title: Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehn076 – volume: 10 start-page: 421 year: 1999 ident: 2021113010082138300_B172 article-title: Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice publication-title: Immunity doi: 10.1016/S1074-7613(00)80042-4 – start-page: 279 volume-title: Metabolic Syndrome year: 2005 ident: 2021113010082138300_B1 article-title: Non-alcoholic steatatohepatitis doi: 10.1002/0470025131.ch11 – volume: 100 start-page: 278 year: 2008 ident: 2021113010082138300_B207 article-title: Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPARα promoter of the offspring publication-title: Br. J. Nutr. doi: 10.1017/S0007114507894438 – volume: 127 start-page: 20 year: 2007 ident: 2021113010082138300_B227 article-title: Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease publication-title: Am. J. Clin. Pathol. doi: 10.1309/JXWUM661T8VT1ETX – volume: 50 start-page: 1844 year: 2001 ident: 2021113010082138300_B149 article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome publication-title: Diabetes doi: 10.2337/diabetes.50.8.1844 – volume: 103 start-page: 1489 year: 1999 ident: 2021113010082138300_B154 article-title: Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting publication-title: J. Clin. Invest. doi: 10.1172/JCI6223 – volume: 289 start-page: E30 year: 2005 ident: 2021113010082138300_B51 article-title: Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00251.2004 – volume: 120 start-page: 1183 year: 2001 ident: 2021113010082138300_B193 article-title: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities publication-title: Gastroenterology doi: 10.1053/gast.2001.23256 – volume: 132 start-page: 112 year: 2000 ident: 2021113010082138300_B4 article-title: Prevalence of and risk factors for hepatic steatosis in Northern Italy publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-132-2-200001180-00004 – volume: 54 start-page: 1907 year: 2005 ident: 2021113010082138300_B80 article-title: Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men publication-title: Diabetes doi: 10.2337/diabetes.54.7.1907 – volume: 22 start-page: S96 year: 2007 ident: 2021113010082138300_B115 article-title: Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2006.04665.x – volume: 313 start-page: 1137 year: 2006 ident: 2021113010082138300_B168 article-title: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes publication-title: Science doi: 10.1126/science.1128294 – volume: 53 start-page: 750 year: 2004 ident: 2021113010082138300_B16 article-title: Long term prognosis of fatty liver: risk of chronic liver disease and death publication-title: Gut doi: 10.1136/gut.2003.019984 – volume: 306 start-page: 457 year: 2004 ident: 2021113010082138300_B170 article-title: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes publication-title: Science doi: 10.1126/science.1103160 – volume: 42 start-page: 650 year: 2005 ident: 2021113010082138300_B215 article-title: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women publication-title: Hepatology doi: 10.1002/hep.20818 – volume: 1 start-page: 309 year: 2005 ident: 2021113010082138300_B95 article-title: ‘New’ hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis publication-title: Cell Metab. doi: 10.1016/j.cmet.2005.04.002 – volume: 273 start-page: 35299 year: 1998 ident: 2021113010082138300_B103 article-title: Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.52.35299 – volume: 37 start-page: 1286 year: 2003 ident: 2021113010082138300_B217 article-title: Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values publication-title: Hepatology doi: 10.1053/jhep.2003.50229 – volume: 47 start-page: 625 year: 2008 ident: 2021113010082138300_B99 article-title: Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.21988 – volume: 46 start-page: 122 year: 2007 ident: 2021113010082138300_B178 article-title: Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats publication-title: Hepatology doi: 10.1002/hep.21641 – volume: 36 start-page: 55 year: 2002 ident: 2021113010082138300_B190 article-title: Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-α-induced apoptosis in cultured mouse hepatocytes publication-title: Hepatology doi: 10.1053/jhep.2002.33995 – volume: 99 start-page: 1708 year: 2004 ident: 2021113010082138300_B186 article-title: Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2004.40009.x – volume: 277 start-page: 9562 year: 2002 ident: 2021113010082138300_B155 article-title: Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110132200 – volume: 110 start-page: 1383 year: 2002 ident: 2021113010082138300_B169 article-title: Translational control in the endoplasmic reticulum stress response publication-title: J. Clin. Invest. doi: 10.1172/JCI0216784 – volume: 274 start-page: 29683 year: 1999 ident: 2021113010082138300_B82 article-title: Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.42.29683 – volume: 277 start-page: E1 year: 1999 ident: 2021113010082138300_B198 article-title: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes publication-title: Am. J. Physiol. – volume: 366 start-page: 377 year: 2002 ident: 2021113010082138300_B100 article-title: New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c publication-title: Biochem. J. doi: 10.1042/bj20020430 – volume: 141 start-page: 946 year: 2004 ident: 2021113010082138300_B30 article-title: Narrative review: hepatobiliary disease in type 2 diabetes mellitus publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-141-12-200412210-00011 – volume: 36 start-page: 662 year: 2004 ident: 2021113010082138300_B118 article-title: Increase of PTEN gene expression in insulin resistance publication-title: Horm. Metab. Res. doi: 10.1055/s-2004-826016 – volume: 280 start-page: 22523 year: 2005 ident: 2021113010082138300_B119 article-title: PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes publication-title: J. Biol. Chem. doi: 10.1074/jbc.M501949200 – volume: 420 start-page: 333 year: 2002 ident: 2021113010082138300_B140 article-title: A central role for JNK in obesity and insulin resistance publication-title: Nature doi: 10.1038/nature01137 – volume: 14 start-page: 963 year: 2000 ident: 2021113010082138300_B107 article-title: Leptin-specific patterns of gene expression in white adipose tissue publication-title: Genes Dev. doi: 10.1101/gad.14.8.963 – volume: 17 start-page: 863 year: 2007 ident: 2021113010082138300_B45 article-title: Nonalcoholic fatty liver disease publication-title: Ann. Epidemiol. doi: 10.1016/j.annepidem.2007.05.013 – volume: 115 start-page: 1343 year: 2005 ident: 2021113010082138300_B49 article-title: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease publication-title: J. Clin. Invest. doi: 10.1172/JCI23621 – volume: 147 start-page: 943 year: 2006 ident: 2021113010082138300_B67 article-title: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis publication-title: Endocrinology doi: 10.1210/en.2005-0570 – volume: 36 start-page: 232 year: 2005 ident: 2021113010082138300_B50 article-title: Regulation of plasma triglycerides in insulin resistance and diabetes publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2005.01.005 – volume: 91 start-page: 4753 year: 2006 ident: 2021113010082138300_B54 article-title: The role of insulin resistance in nonalcoholic fatty liver disease publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2006-0587 – volume: 11 start-page: 119 year: 2007 ident: 2021113010082138300_B171 article-title: Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.12.016 – volume: 40 start-page: 1387 year: 2004 ident: 2021113010082138300_B2 article-title: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity publication-title: Hepatology doi: 10.1002/hep.20466 – volume: 164 start-page: 2169 year: 2004 ident: 2021113010082138300_B7 article-title: Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults publication-title: Arch. Intern. Med. doi: 10.1001/archinte.164.19.2169 – volume: 409 start-page: 92 year: 2001 ident: 2021113010082138300_B112 article-title: The lipid phosphatase SHIP2 controls insulin sensitivity publication-title: Nature doi: 10.1038/35051094 – volume: 82 start-page: 216 year: 1999 ident: 2021113010082138300_B70 article-title: Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFκB activity publication-title: J. Surg. Res. doi: 10.1006/jsre.1998.5524 – volume: 108 start-page: 1167 year: 2001 ident: 2021113010082138300_B109 article-title: Role of AMP-activated protein kinase in mechanism of metformin action publication-title: J. Clin. Invest. doi: 10.1172/JCI13505 – volume: 130 start-page: 207 year: 2006 ident: 2021113010082138300_B166 article-title: From fat to inflammation publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.017 – volume: 275 start-page: 12889 year: 2000 ident: 2021113010082138300_B116 article-title: The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.17.12889 – volume: 127 start-page: 1704 year: 2004 ident: 2021113010082138300_B24 article-title: Serum markers detect the presence of liver fibrosis: a cohort study publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.08.052 – volume: 118 start-page: 1388 year: 2006 ident: 2021113010082138300_B14 article-title: Prevalence of fatty liver in children and adolescents publication-title: Pediatrics doi: 10.1542/peds.2006-1212 – volume: 112 start-page: 89 year: 2006 ident: 2021113010082138300_B111 article-title: PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling publication-title: Arch. Physiol. Biochem. doi: 10.1080/13813450600711359 – volume: 40 start-page: 185 year: 2004 ident: 2021113010082138300_B167 article-title: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway publication-title: Hepatology doi: 10.1002/hep.20283 – volume: 73 start-page: 457 year: 1993 ident: 2021113010082138300_B174 article-title: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L publication-title: monocytogenes infection. Cell – volume: 346 start-page: 1221 year: 2002 ident: 2021113010082138300_B21 article-title: Nonalcoholic fatty liver disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra011775 – volume: 40 start-page: 820 year: 2004 ident: 2021113010082138300_B19 article-title: Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies publication-title: Hepatology – volume: 285 start-page: E906 year: 2003 ident: 2021113010082138300_B56 article-title: Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00117.2003 – volume: 4 start-page: 107 year: 2006 ident: 2021113010082138300_B135 article-title: Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis publication-title: Cell Metab. doi: 10.1016/j.cmet.2006.06.008 – volume: 40 start-page: 1469 year: 2005 ident: 2021113010082138300_B222 article-title: Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease publication-title: Scand. J. Gastroenterol. doi: 10.1080/00365520500264953 – volume: 8 start-page: 1288 year: 2002 ident: 2021113010082138300_B175 article-title: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase publication-title: Nat. Med. doi: 10.1038/nm788 – volume: 21 start-page: 57 year: 2001 ident: 2021113010082138300_B189 article-title: Mitochondria in steatohepatitis publication-title: Semin. Liver Dis. doi: 10.1055/s-2001-12929 – volume: 54 start-page: 3541 year: 2005 ident: 2021113010082138300_B37 article-title: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients publication-title: Diabetes doi: 10.2337/diabetes.54.12.3541 – volume: 103 start-page: 8552 year: 2006 ident: 2021113010082138300_B92 article-title: Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0603115103 – volume: 49 start-page: 141 year: 2006 ident: 2021113010082138300_B28 article-title: Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects publication-title: Diabetologia doi: 10.1007/s00125-005-0070-x – volume: 12 start-page: 740 year: 2007 ident: 2021113010082138300_B101 article-title: Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD) publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2007.07.009 – volume: 54 start-page: 1958 year: 2005 ident: 2021113010082138300_B113 article-title: Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice publication-title: Diabetes doi: 10.2337/diabetes.54.7.1958 – volume: 288 start-page: R112 year: 2005 ident: 2021113010082138300_B214 article-title: High-unsaturated-fat, high-protein, and low-carbohydrate diet during pregnancy and lactation modulates hepatic lipid metabolism in female adult offspring publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00351.2004 – volume: 24 start-page: 355 year: 1998 ident: 2021113010082138300_B223 article-title: Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity publication-title: Diabetes Metab. – volume: 26 start-page: 3351 year: 2003 ident: 2021113010082138300_B13 article-title: Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics publication-title: Diabetes Care doi: 10.2337/diacare.26.12.3351-a – volume: 38 start-page: 954 year: 2003 ident: 2021113010082138300_B9 article-title: Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background publication-title: J. Gastroenterol. doi: 10.1007/s00535-003-1178-8 – volume: 288 start-page: E462 year: 2005 ident: 2021113010082138300_B3 article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00064.2004 – volume: 83 start-page: 2907 year: 1998 ident: 2021113010082138300_B163 article-title: Tumor necrosis factor-α in sera of obese patients: fall with weight loss publication-title: J. Clin. Endocrinol. Metab. – volume: 432 start-page: 1027 year: 2004 ident: 2021113010082138300_B110 article-title: Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes publication-title: Nature doi: 10.1038/nature03047 – volume: 104 start-page: 12796 year: 2007 ident: 2021113010082138300_B204 article-title: Metabolic plasticity during mammalian development is directionally dependent on early nutritional status publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0705667104 – volume: 90 start-page: 5723 year: 1993 ident: 2021113010082138300_B122 article-title: Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.90.12.5723 – volume: 6 start-page: 1 year: 2006 ident: 2021113010082138300_B209 article-title: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it publication-title: Mitochondrion doi: 10.1016/j.mito.2005.10.004 – volume: 26 start-page: 98 year: 2000 ident: 2021113010082138300_B62 article-title: Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss publication-title: Diabetes Metab. – volume: 112 start-page: 1821 year: 2003 ident: 2021113010082138300_B147 article-title: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance publication-title: J. Clin. Invest. doi: 10.1172/JCI200319451 – volume: 84 start-page: 1513 year: 1999 ident: 2021113010082138300_B63 article-title: Liver pathology and the metabolic syndrome X in severe obesity publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.5.5661 – volume: 51 start-page: 1005 year: 2002 ident: 2021113010082138300_B55 article-title: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments publication-title: Diabetes doi: 10.2337/diabetes.51.4.1005 – volume: 97 start-page: 1444 year: 2000 ident: 2021113010082138300_B90 article-title: The subcellular localization of acetyl-CoA carboxylase 2 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.97.4.1444 – volume: 11 start-page: 183 year: 2005 ident: 2021113010082138300_B150 article-title: Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB publication-title: Nat. Med. doi: 10.1038/nm1166 – volume: 37 start-page: 343 year: 2003 ident: 2021113010082138300_B194 article-title: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1053/jhep.2003.50048 – volume: 27 start-page: 1881 year: 2007 ident: 2021113010082138300_B93 article-title: Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.01122-06 – volume: 118 start-page: 829 year: 2008 ident: 2021113010082138300_B47 article-title: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice publication-title: J. Clin. Invest. doi: 10.1172/JCI34275 – volume: 57 start-page: 569 year: 2008 ident: 2021113010082138300_B43 article-title: Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men publication-title: Metab. Clin. Exp. doi: 10.1016/j.metabol.2007.11.022 – volume: 34 start-page: 1158 year: 2001 ident: 2021113010082138300_B191 article-title: Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients publication-title: Hepatology doi: 10.1053/jhep.2001.29628 – volume: 1380 start-page: 336 year: 1998 ident: 2021113010082138300_B152 article-title: Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits publication-title: Biochim. Biophys. Acta doi: 10.1016/S0304-4165(98)00002-6 – volume: 19 start-page: 1564 year: 2008 ident: 2021113010082138300_B42 article-title: Increased risk of CKD among Type 2 diabetics with nonalcoholic fatty liver disease publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2007101155 – volume: 22 start-page: 1141 year: 2005 ident: 2021113010082138300_B6 article-title: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults publication-title: Diabetic Med. doi: 10.1111/j.1464-5491.2005.01582.x – volume: 43 start-page: 1145 year: 2006 ident: 2021113010082138300_B34 article-title: Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States publication-title: Hepatology doi: 10.1002/hep.21171 – volume: 6 start-page: 484 year: 2007 ident: 2021113010082138300_B98 article-title: Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.10.014 – volume: 15 start-page: 1206 year: 2001 ident: 2021113010082138300_B108 article-title: SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation publication-title: Genes Dev. doi: 10.1101/gad.891301 – volume: 116 start-page: 1413 year: 1999 ident: 2021113010082138300_B20 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 101 start-page: 2082 year: 2004 ident: 2021113010082138300_B121 article-title: Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0308617100 – volume: 14 start-page: 222 year: 2008 ident: 2021113010082138300_B162 article-title: Inflammatory mechanisms in the regulation of insulin resistance publication-title: Mol. Med. doi: 10.2119/2007-00119.Tilg – volume: 8 start-page: 521 year: 2004 ident: 2021113010082138300_B29 article-title: The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease publication-title: Clin. Liver Dis. doi: 10.1016/j.cld.2004.04.004 – volume: 141 start-page: 4021 year: 2000 ident: 2021113010082138300_B195 article-title: Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice publication-title: Endocrinology doi: 10.1210/endo.141.11.7771 – volume: 118 start-page: 3160 year: 2008 ident: 2021113010082138300_B179 article-title: Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice publication-title: J. Clin. Invest. doi: 10.1172/JCI34827 – volume: 29 start-page: 1325 year: 2006 ident: 2021113010082138300_B39 article-title: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease publication-title: Diabetes Care doi: 10.2337/dc06-0135 – volume: 262 start-page: 2050 year: 1987 ident: 2021113010082138300_B197 article-title: Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)61616-3 – volume: 42 start-page: 44 year: 2005 ident: 2021113010082138300_B17 article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study publication-title: Hepatology doi: 10.1002/hep.20734 – volume: 121 start-page: 72 year: 2008 ident: 2021113010082138300_B38 article-title: Carotid artery intima-media thickness in nonalcoholic fatty liver disease publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2007.08.041 – volume: 291 start-page: 2613 year: 2001 ident: 2021113010082138300_B89 article-title: Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 publication-title: Science doi: 10.1126/science.1056843 – volume: 99 start-page: 540 year: 2008 ident: 2021113010082138300_B201 article-title: The nature of the growth pattern and of the metabolic response to fasting in the rat are dependent upon the dietary protein and folic acid intakes of their pregnant dams and post-weaning fat consumption publication-title: Br. J. Nutr. doi: 10.1017/S0007114507815819 – volume: 11 start-page: 437 year: 2001 ident: 2021113010082138300_B126 article-title: Insulin resistance: a phosphorylation-based uncoupling of insulin signaling publication-title: Trends Cell Biol. doi: 10.1016/S0962-8924(01)81297-6 – volume: 26 start-page: 63 year: 2006 ident: 2021113010082138300_B128 article-title: Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.26.1.63-76.2006 – volume: 264 start-page: 11584 year: 1989 ident: 2021113010082138300_B134 article-title: Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)80103-X – volume: 279 start-page: 32345 year: 2004 ident: 2021113010082138300_B151 article-title: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease publication-title: J. Biol. Chem. doi: 10.1074/jbc.M313478200 – volume: 38 start-page: 420 year: 2003 ident: 2021113010082138300_B22 article-title: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C publication-title: Hepatology doi: 10.1053/jhep.2003.50320 – volume: 135 start-page: 1382 year: 2005 ident: 2021113010082138300_B206 article-title: Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring publication-title: J. Nutr. doi: 10.1093/jn/135.6.1382 – volume: 17 start-page: 77 year: 1997 ident: 2021113010082138300_B91 article-title: Regulation of mammalian acetyl-coenzyme A carboxylase publication-title: Annu. Rev. Nutr. doi: 10.1146/annurev.nutr.17.1.77 – volume: 13 start-page: 190 year: 1993 ident: 2021113010082138300_B73 article-title: High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis publication-title: Arterioscler. Thromb. doi: 10.1161/01.ATV.13.2.190 – volume: 13 start-page: 4539 year: 2007 ident: 2021113010082138300_B183 article-title: Pathogenesis and management issues for non-alcoholic fatty liver disease publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v13.i34.4539 – volume: 278 start-page: 21851 year: 2003 ident: 2021113010082138300_B85 article-title: A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301982200 – volume: 95 start-page: 5987 year: 1998 ident: 2021113010082138300_B105 article-title: Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.95.11.5987 – volume: 61 start-page: 5R year: 2007 ident: 2021113010082138300_B205 article-title: Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease publication-title: Pediatr. Res. doi: 10.1203/pdr.0b013e318045bedb – volume: 142 start-page: 699 year: 1995 ident: 2021113010082138300_B32 article-title: γ-Glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes publication-title: Am. J. Epidemiol. doi: 10.1093/oxfordjournals.aje.a117699 – volume: 23 start-page: 1143 year: 2006 ident: 2021113010082138300_B74 article-title: Prolonged n−3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/j.1365-2036.2006.02885.x – volume: 101 start-page: 15597 year: 2004 ident: 2021113010082138300_B137 article-title: Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0405238101 – volume: 86 start-page: 285 year: 2007 ident: 2021113010082138300_B66 article-title: Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/86.2.285 – volume: 37 start-page: 909 year: 2003 ident: 2021113010082138300_B68 article-title: Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1053/jhep.2003.50132 – volume: 283 start-page: E1135 year: 2002 ident: 2021113010082138300_B57 article-title: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.0327.2001 – volume: 22 start-page: 788 year: 2007 ident: 2021113010082138300_B8 article-title: How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2007.05042.x – volume: 204 start-page: 263 year: 2005 ident: 2021113010082138300_B199 article-title: Hepatic mitochondrial glutathione: transport and role in disease and toxicity publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2004.10.001 – volume: 284 start-page: L84 year: 2003 ident: 2021113010082138300_B71 article-title: NF-κB inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol. doi: 10.1152/ajplung.00077.2002 – volume: 43 start-page: 508 year: 2005 ident: 2021113010082138300_B10 article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China publication-title: J. Hepatol. doi: 10.1016/j.jhep.2005.02.042 – volume: 277 start-page: 31646 year: 2002 ident: 2021113010082138300_B81 article-title: Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction publication-title: J. Biol. Chem. doi: 10.1074/jbc.M200544200 – volume: 116 start-page: 817 year: 2006 ident: 2021113010082138300_B94 article-title: Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2 publication-title: J. Clin. Invest. doi: 10.1172/JCI27300 – volume: 45 start-page: 846 year: 2007 ident: 2021113010082138300_B25 article-title: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD publication-title: Hepatology doi: 10.1002/hep.21496 – volume: 274 start-page: 35840 year: 1999 ident: 2021113010082138300_B104 article-title: A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.50.35840 – volume: 40 start-page: 46 year: 2004 ident: 2021113010082138300_B176 article-title: Beyond insulin resistance in NASH: TNF-α or adiponectin? publication-title: Hepatology doi: 10.1002/hep.20280 – volume: 274 start-page: E321 year: 1998 ident: 2021113010082138300_B88 article-title: Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification publication-title: Am. J. Physiol. – volume: 97 start-page: 1036 year: 2007 ident: 2021113010082138300_B200 article-title: Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? publication-title: Br. J. Nutr. doi: 10.1017/S0007114507682920 – volume: 228 start-page: E663 year: 1975 ident: 2021113010082138300_B144 article-title: Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice publication-title: Am. J. Physiol. doi: 10.1152/ajplegacy.1975.228.2.663 – volume: 24 start-page: 1007 year: 2004 ident: 2021113010082138300_B124 article-title: Suppression of PTEN expression by NF-κB prevents apoptosis publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.24.3.1007-1021.2004 – volume: 277 start-page: 42358 year: 2002 ident: 2021113010082138300_B86 article-title: An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins publication-title: J. Biol. Chem. doi: 10.1074/jbc.M204542200 – volume: 97 start-page: 2081 year: 1996 ident: 2021113010082138300_B61 article-title: Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet publication-title: J. Clin. Invest. doi: 10.1172/JCI118645 – volume: 133 start-page: 3386 year: 2003 ident: 2021113010082138300_B83 article-title: Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice publication-title: J. Nutr. doi: 10.1093/jn/133.11.3386 – volume: 65 start-page: 774 year: 1992 ident: 2021113010082138300_B12 article-title: Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management publication-title: Br. J. Radiol. doi: 10.1259/0007-1285-65-777-774 – volume: 52 start-page: 2453 year: 2003 ident: 2021113010082138300_B59 article-title: Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog publication-title: Diabetes doi: 10.2337/diabetes.52.10.2453 – volume: 121 start-page: 91 year: 2001 ident: 2021113010082138300_B5 article-title: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese publication-title: Gastroenterology doi: 10.1053/gast.2001.25540 – volume: 104 start-page: 343 year: 1988 ident: 2021113010082138300_B69 article-title: Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation publication-title: Surgery – volume: 362 start-page: 206 year: 2007 ident: 2021113010082138300_B132 article-title: Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2007.08.004 – volume: 15 start-page: 1411 year: 2001 ident: 2021113010082138300_B117 article-title: Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes publication-title: Mol. Endocrinol. doi: 10.1210/mend.15.8.0684 – volume: 278 start-page: 498 year: 2003 ident: 2021113010082138300_B123 article-title: Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression publication-title: J. Biol. Chem. doi: 10.1074/jbc.M210062200 – volume: 40 start-page: 60 year: 2004 ident: 2021113010082138300_B185 article-title: 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells publication-title: J. Hepatol. doi: 10.1016/S0168-8278(03)00480-X – volume: 22 start-page: S20 year: 2007 ident: 2021113010082138300_B159 article-title: Role of mitochondria in non-alcoholic fatty liver disease publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2006.04640.x – volume: 49 start-page: 3049 year: 2006 ident: 2021113010082138300_B131 article-title: Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice publication-title: Diabetologia doi: 10.1007/s00125-006-0439-5 – volume: 91 start-page: 1125 year: 2007 ident: 2021113010082138300_B44 article-title: Nonalcoholic fatty liver disease as a complication of insulin resistance publication-title: Med. Clin. North Am. doi: 10.1016/j.mcna.2007.06.001 – volume: 417 start-page: 861 year: 2002 ident: 2021113010082138300_B173 article-title: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 publication-title: Nature doi: 10.1038/nature00820 – volume: 50 start-page: 1024 year: 2007 ident: 2021113010082138300_B212 article-title: Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men publication-title: Diabetologia doi: 10.1007/s00125-007-0629-9 – volume: 113 start-page: 1774 year: 2004 ident: 2021113010082138300_B120 article-title: Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas publication-title: J. Clin. Invest. doi: 10.1172/JCI20513 – volume: 46 start-page: 1532 year: 2003 ident: 2021113010082138300_B127 article-title: MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632 publication-title: Diabetologia doi: 10.1007/s00125-003-1223-4 – volume: 284 start-page: E1065 year: 2003 ident: 2021113010082138300_B58 article-title: Visceral fat and liver fat are independent predictors of metabolic risk factors in men publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00442.2002 – volume: 360 start-page: 1323 year: 2002 ident: 2021113010082138300_B210 article-title: Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? publication-title: Lancet doi: 10.1016/S0140-6736(02)11310-9 – volume: 30 start-page: 1356 year: 1999 ident: 2021113010082138300_B218 article-title: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.510300604 – volume: 87 start-page: 81 year: 2005 ident: 2021113010082138300_B78 article-title: Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver publication-title: Biochimie doi: 10.1016/j.biochi.2004.11.008 – volume: 54 start-page: 987 year: 2005 ident: 2021113010082138300_B184 article-title: Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis publication-title: Gut doi: 10.1136/gut.2004.057968 – volume: 354 start-page: 189 year: 2001 ident: 2021113010082138300_B196 article-title: Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor α (PPARα)-independent pathway publication-title: Biochem. J. doi: 10.1042/bj3540189 – volume: 341 start-page: 248 year: 1999 ident: 2021113010082138300_B139 article-title: Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199907223410406 – volume: 2 start-page: 273 year: 2005 ident: 2021113010082138300_B146 article-title: Adipocytokines and visceral adipose tissue:emerging role in nonalcoholic fatty liver disease publication-title: Nat. Clin. Pract. Gastroenterol. Hepatol. doi: 10.1038/ncpgasthep0186 – volume: 282 start-page: 1659 year: 1999 ident: 2021113010082138300_B157 article-title: Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study publication-title: JAMA, J. Am. Med. Assoc. doi: 10.1001/jama.282.17.1659 – volume: 29 start-page: 236S year: 2005 ident: 2021113010082138300_B226 article-title: Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study publication-title: Alcohol Clin. Exp. Res. doi: 10.1097/01.alc.0000190659.85025.b3 – volume: 22 start-page: 554 year: 2005 ident: 2021113010082138300_B26 article-title: Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study publication-title: Diabetic Med. doi: 10.1111/j.1464-5491.2005.01494.x – volume: 129 start-page: 113 year: 2005 ident: 2021113010082138300_B18 article-title: The natural history of nonalcoholic fatty liver disease: a population-based cohort study publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.04.014 – volume: 144 start-page: 3456 year: 2003 ident: 2021113010082138300_B52 article-title: Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice publication-title: Endocrinology doi: 10.1210/en.2002-0036 – volume: 101 start-page: 11245 year: 2004 ident: 2021113010082138300_B141 article-title: Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0404297101 – volume: 78 start-page: 73 year: 2008 ident: 2021113010082138300_B203 article-title: Sex, but not maternal protein or folic acid intake, determines the fatty acid composition of hepatic phospholipids, but not of triacylglycerol, in adult rats. Prostaglandins Leukotrienes Essent publication-title: Fatty Acids doi: 10.1016/j.plefa.2007.10.028 – volume: 52 start-page: 2375 year: 2007 ident: 2021113010082138300_B219 article-title: Association among C-reactive protein, Fatty liver disease, and cardiovascular risk publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-006-9262-6 – volume: 52 start-page: 2882 year: 2003 ident: 2021113010082138300_B187 article-title: Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects publication-title: Diabetes doi: 10.2337/diabetes.52.12.2882 – volume: 51 start-page: 444 year: 2008 ident: 2021113010082138300_B41 article-title: Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients publication-title: Diabetologia doi: 10.1007/s00125-007-0897-4 – volume: 23 start-page: 71 year: 2004 ident: 2021113010082138300_B72 article-title: Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2004.10719345 – volume: 153 start-page: 191 year: 1988 ident: 2021113010082138300_B153 article-title: Evidence for mitochondrial DNA damage by lipid peroxidation publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(88)81207-5 – volume: 6 start-page: 77 year: 2000 ident: 2021113010082138300_B106 article-title: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice publication-title: Mol. Cell doi: 10.1016/S1097-2765(05)00010-9 – volume: 112 start-page: 1796 year: 2003 ident: 2021113010082138300_B182 article-title: Obesity is associated with macrophage accumulation in adipose tissue publication-title: J. Clin. Invest. doi: 10.1172/JCI200319246 – volume: 20 start-page: 1825 year: 2005 ident: 2021113010082138300_B11 article-title: Fatty liver and the metabolic syndrome among Shanghai adults publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2005.04058.x – volume: 21 start-page: 5050 year: 2001 ident: 2021113010082138300_B125 article-title: Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.21.15.5050-5062.2001 – volume: 8 start-page: 445 year: 2004 ident: 2021113010082138300_B188 article-title: Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2004.tb00469.x – volume: 97 start-page: 435 year: 2007 ident: 2021113010082138300_B202 article-title: Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations publication-title: Br. J. Nutr. doi: 10.1017/S0007114507352392 – volume: 31 start-page: 1851 year: 2000 ident: 2021113010082138300_B31 article-title: Serum γ-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke publication-title: Stroke doi: 10.1161/01.STR.31.8.1851 – volume: 31 start-page: 1152 year: 2003 ident: 2021113010082138300_B129 article-title: Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0311152 – volume: 160 start-page: 377 year: 2002 ident: 2021113010082138300_B221 article-title: Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00588-3 – volume: 30 start-page: 1212 year: 2007 ident: 2021113010082138300_B36 article-title: Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients publication-title: Diabetes Care doi: 10.2337/dc06-2247 – volume: 114 start-page: 1752 year: 2004 ident: 2021113010082138300_B181 article-title: Increased oxidative stress in obesity and its impact on metabolic syndrome publication-title: J. Clin. Invest. doi: 10.1172/JCI21625 – volume: 31 start-page: 430 year: 1999 ident: 2021113010082138300_B156 article-title: Mitochondrial abnormalities in non-alcoholic steatohepatitis publication-title: J. Hepatol. doi: 10.1016/S0168-8278(99)80033-6 – volume: 3 start-page: 420 year: 2003 ident: 2021113010082138300_B138 article-title: JNK: a new therapeutic target for diabetes publication-title: Curr. Opin. Pharmacol. doi: 10.1016/S1471-4892(03)00068-7 – volume: 100 start-page: 9476 year: 2003 ident: 2021113010082138300_B110a article-title: Insig-1 “brakes” lipogenesis in adipocytes and inhibits differentiation of preadipocytes publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1133426100 – volume: 38 start-page: 999 year: 2003 ident: 2021113010082138300_B158 article-title: Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.1840380426 – volume: 2 start-page: 1048 year: 2004 ident: 2021113010082138300_B46 article-title: Nonalcoholic fatty liver disease: a review of current understanding and future impact publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/S1542-3565(04)00440-9 – volume: 37 start-page: 544 year: 2003 ident: 2021113010082138300_B192 article-title: Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1053/jhep.2003.50095 – volume: 277 start-page: 27029 year: 2002 ident: 2021113010082138300_B133 article-title: The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression publication-title: J. Biol. Chem. doi: 10.1074/jbc.M202638200 – volume: 11 start-page: 1848 year: 2005 ident: 2021113010082138300_B40 article-title: Hepatic steatosis is associated with an increased risk of carotid atherosclerosis publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v11.i12.1848 – volume: 23 start-page: 267 year: 2008 ident: 2021113010082138300_B76 article-title: Activation of peroxisome proliferator-activated receptor α by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2007.05157.x – volume: 35 start-page: 1485 year: 2002 ident: 2021113010082138300_B23 article-title: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis publication-title: Hepatology doi: 10.1053/jhep.2002.33324 – volume: 57 start-page: 387 year: 2008 ident: 2021113010082138300_B35 article-title: Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study publication-title: Metab. Clin. Exp. doi: 10.1016/j.metabol.2007.10.015 – volume: 42 start-page: 928 year: 2005 ident: 2021113010082138300_B160 article-title: NASH: a mitochondrial disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2005.03.004 – volume: 54 start-page: 117 year: 2005 ident: 2021113010082138300_B177 article-title: Adiponectin and its receptors in non-alcoholic steatohepatitis publication-title: Gut doi: 10.1136/gut.2003.037010 – volume: 42 start-page: 573 year: 2007 ident: 2021113010082138300_B220 article-title: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH publication-title: J. Gastroenterol. doi: 10.1007/s00535-007-2060-x – volume: 132 start-page: 68 year: 2002 ident: 2021113010082138300_B87 article-title: Choline deficiency-induced liver damage is reversible in Pemt(−/−) mice publication-title: J. Nutr. doi: 10.1093/jn/132.1.68 – volume: 191 start-page: 391 year: 2007 ident: 2021113010082138300_B33 article-title: Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.04.006 – volume: 9 start-page: 418 year: 2004 ident: 2021113010082138300_B211 article-title: Mitochondrial DNA turnover occurs during preimplantation development and can be modulated by environmental factors publication-title: Reprod. Biomed. Online doi: 10.1016/S1472-6483(10)61277-1 – volume: 11 start-page: 525 year: 2003 ident: 2021113010082138300_B145 article-title: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression publication-title: Obes. Res. doi: 10.1038/oby.2003.74 – volume: 44 start-page: 356 year: 2003 ident: 2021113010082138300_B143 article-title: SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium-chain fatty acids on ACCα transcription in hepatocytes publication-title: J. Lipid Res. doi: 10.1194/jlr.M200283-JLR200 – volume: 272 start-page: 29911 year: 1997 ident: 2021113010082138300_B164 article-title: A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.47.29911 – volume: 43 start-page: 1035 year: 2002 ident: 2021113010082138300_B84 article-title: Inhibition of phosphatidylcholine synthesis via the phosphatidylethanolamine methylation pathway impairs incorporation of bulk lipids into VLDL in cultured rat hepatocytes publication-title: J. Lipid Res. doi: 10.1194/jlr.M100354-JLR200 – volume: 95 start-page: 833 year: 2006 ident: 2021113010082138300_B15 article-title: Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging publication-title: Acta Paediatr. doi: 10.1080/08035250500449890 – volume: 99 start-page: 1497 year: 2004 ident: 2021113010082138300_B224 article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2004.30159.x – volume: 97 start-page: 1064 year: 2007 ident: 2021113010082138300_B208 article-title: Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications publication-title: Br. J. Nutr. doi: 10.1017/S000711450769196X |
| SSID | ssj0023232 |
| Score | 2.3712907 |
| SecondaryResourceType | review_article |
| Snippet | NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis),... |
| SourceID | proquest pubmed pascalfrancis crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 539 |
| SubjectTerms | Biological and medical sciences Biomarkers - blood Cardiovascular Diseases - etiology Diet - adverse effects Fatty Liver - diagnosis Fatty Liver - epidemiology Fatty Liver - etiology Fatty Liver - metabolism Gastroenterology. Liver. Pancreas. Abdomen General aspects Humans Inflammation - complications Lipogenesis Liver - metabolism Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Other diseases. Semiology Oxidative Stress |
| Title | Metabolic disturbances in non-alcoholic fatty liver disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/19243311 https://www.proquest.com/docview/66957292 |
| Volume | 116 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1470-8736 dateEnd: 20231002 omitProxy: true ssIdentifier: ssj0023232 issn: 0143-5221 databaseCode: GX1 dateStart: 19790101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAgJIe6Uy4gELzwEcrEdWzyFsm5cOtBYpe4pcuJYmjR1Y01f-PWcYydOMoa49MGqUseu_H06Psc-F0JesjLihnEdKoElzHisQ7xtCxVIvjoRhgpbrWG-z_cW9OOSLQc3phhd0pSvqx-XxpX8D6rwDHDFKNl_QNYPCg_gO-ALLSAM7V9hPK8bwBDTVGtAa3NeIoTWwRWM-lC56rfwq1ENFohAF4zRjUyXoWAUHVlZrTOWmRycErw7OtjfuZCMoHcW_vJ5Mcvff7BwqbX67t86WEztW5-Ose4Iyh__zjTfzedfcxcyNcOo-NPWebE7g5AD1xVkDTq9nrjght5txJ1WpmDpuhBoL25dbGXLqywUA_HJXGKjdidmLr_5L0Ie5AwgU60TGyjscg2PM2lf2OG83yHs05hwjl0l15KMc6x4sbv0LkGgXNqCdv5vd-lsafKmn22kwNw8U2vAx7giKL-3Uqy2cnib3GrNjCB3nLlDrtSru-T6vHWkuEfeeuoEQ-oEx6tgRJ3AUiew1Ala6twni9nO4XQvbOtohBXoY02YsgiM8CxNjaaxiRVndcZlmaookYpqGin4CCN1GUlhdCa0rkDLlTXVXKQVSx-QLZi7fkQCwYwuqaAiwobBKKVMdGZAD9TSMDUhr7rFKao2yTzWOjkprLMDTYrpt24hJ-SF73vmUqtc2mt7tMa-a4flhDzvFr0A0Yj3XWpVn27WBeeSge2YTMhDh0U_jUwwUjB-_KfBn5AbPd-fkq3mfFM_Ay20KbctdX4CPuCCwQ |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+disturbances+in+non-alcoholic+fatty+liver+disease&rft.jtitle=Clinical+science+%281979%29&rft.au=BYRNE%2C+Christopher+D&rft.au=OLUFADI%2C+Rasaq&rft.au=BRUCE%2C+Kimberley+D&rft.au=CAGAMPANG%2C+Felino+R&rft.date=2009-04-01&rft.pub=Portland+Press&rft.issn=0143-5221&rft.volume=116&rft.issue=7-8&rft.spage=539&rft.epage=564&rft_id=info:doi/10.1042%2Fcs20080253&rft.externalDBID=n%2Fa&rft.externalDocID=21252735 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-5221&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-5221&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-5221&client=summon |